Recently, we reported that daily intraperitoneal injection of rapamycin at 8 mg/kg attenuates mitochondrial disease symptoms and progression in the Ndufs4 knockout mouse model of Leigh Syndrome. The gene discussed is NDUFS4; the disease is inborn mitochondrial metabolism disorder.